Does Topical Otic Drop Use at Time of Tympanostomy Tube Surgery Improve Outcomes When no Middle Ear Effusion is Present
Launched by BOSTON CHILDREN'S HOSPITAL · Aug 30, 2018
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether using special ear drops during and after tympanostomy tube surgery can help improve outcomes for children who don’t have fluid in their middle ear at the time of the surgery. The surgery is often done to treat frequent ear infections. Researchers want to see if these drops can reduce problems like the tubes getting blocked or drainage from the ear in the first four weeks after surgery. In this study, children aged 6 months to 10 years who are having the surgery for both ears may be eligible, as long as they don’t have any ear fluid or other specific health issues.
If a child participates, they will receive the ear drops in one ear during the surgery and after, while the other ear will not receive the drops. The researchers will track how well the tubes work and whether there’s any drainage from the ear over the following month. It's important to note that children who are having other procedures at the same time or have certain medical conditions won’t be included in the study. Overall, this trial aims to find better ways to ensure successful surgery for kids with ear problems.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participant has a history of Eustachian tube dysfunction (ETD) or recurrent acute otitis media (AOM) requiring surgery for bilateral TT placement
- • Participant's caregiver understands the protocol and is willing to comply with the protocol
- • Children ages 6 months to 10 years undergoing surgery for bilateral tympanostomy tube placement without middle ear fluid on the day of their surgery
- Exclusion Criteria:
- • Participant is having concomitant procedures performed at the time of their tympanostomy tube surgery (i.ei.e. adenoidectomy, airway endoscopy, nasal cautery).
- • Historyof conductive hearing loss, as determined from their last audiogram prior to tympanostomy tube procedure
- • Middle ear effusion present in either their left or right ear on the day of tympanostomy tube surgery
- • Current diagnosis of craniofacial abnormalities, Trisomy 21, primary ciliary dyskinesia, cystic fibrosis
- • History of a known immunodeficiency disease
About Boston Children's Hospital
Boston Children's Hospital is a leading pediatric healthcare institution renowned for its commitment to advancing child health through innovative research and exceptional clinical care. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise in pediatric medicine to conduct rigorous and ethically sound research studies aimed at improving treatment options and outcomes for children. With a collaborative approach that integrates cutting-edge technology and multidisciplinary teams, Boston Children's Hospital is dedicated to translating scientific discoveries into practical applications that enhance the well-being of young patients and their families.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Waltham, Massachusetts, United States
Patients applied
Trial Officials
Kenneth R. Whittemore, MD, MS
Principal Investigator
Boston Children's Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials